prikaz prve stranice dokumenta Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
  Preuzmi
PDF 1.49 MB
Znanstveni rad - Pregledni rad
Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
Canadian Journal of Gastroenterology and Hepatology, 2020 (2020); 1-12. https://doi.org/10.1155/2020/8859719
Mikolašević, Ivana; Pavić, Tajana; Filipec Kanižaj, Tajana; Vranešić Bender, Darija; Domislović, Viktor; Krznarić, Željko

Institucijski repozitorij: Repozitorij Medicinskog fakulteta u Rijeci

Citirajte ovaj rad

Mikolašević, I., Pavić, T., Filipec Kanižaj, T., Vranešić Bender, D., Domislović, V. i Krznarić, Ž. (2020). Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?. Canadian Journal of Gastroenterology and Hepatology, 2020., 1-12. doi: 10.1155/2020/8859719

Mikolašević, Ivana, et al. "Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?." Canadian Journal of Gastroenterology and Hepatology, vol. 2020, 2020, str. 1-12. https://doi.org/10.1155/2020/8859719

Mikolašević, Ivana, Tajana Pavić, Tajana Filipec Kanižaj, Darija Vranešić Bender, Viktor Domislović i Željko Krznarić. "Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?." Canadian Journal of Gastroenterology and Hepatology 2020 (2020): 1-12. https://doi.org/10.1155/2020/8859719

Mikolašević, I., et al. (2020) 'Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?', Canadian Journal of Gastroenterology and Hepatology, 2020, str. 1-12. doi: 10.1155/2020/8859719

Mikolašević I, Pavić T, Filipec Kanižaj T, Vranešić Bender D, Domislović V, Krznarić Ž. Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?. Canadian Journal of Gastroenterology and Hepatology [Internet]. 31.10.2020. [pristupljeno 21.05.2024.];2020:1-12. doi: 10.1155/2020/8859719

I. Mikolašević, T. Pavić, T. Filipec Kanižaj, D. Vranešić Bender, V. Domislović i Ž. Krznarić, "Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?", Canadian Journal of Gastroenterology and Hepatology, vol. 2020, str. 1-12, Listopad 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:506848. [Citirano: 21.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:506848
Podaci o radu
Naslov (engleski)Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
AutorIvana Mikolašević
AutorTajana Pavić
AutorTajana Filipec Kanižaj
AutorDarija Vranešić Bender
AutorViktor Domislović
AutorŽeljko Krznarić
Autorova ustanova(Klinički bolnički centar Sestre milosrdnice)
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
The link between metabolic syndrome (MetS) and sarcopenia has not been extensively studied, but it is evident that they share several common features. Crucial mechanisms involved in sarcopenia-nonalcoholic fatty liver disease (NAFLD) interplay are based on effects of insulin resistance, chronic inflammation, oxidative stress, and crosstalk between organs by secretion of cytokines (hepatokines, adipokines, and myokines). Currently, published studies confirm the association of sarcopenia with the degree of NAFLD defined by liver histology. However, prospective studies that will give us information regarding the causal effect of NAFLD and sarcopenia are still needed. Furthermore, there is a need for a patient-friendly, noninvasive, low-cost method for detection of loss of skeletal muscle mass, strength, and physical performance in the context of NAFLD. Moreover, potential treatment strategies such as physical exercise and nutritional supplementation, that are usually a part of management of sarcopenia, should also be investigated in NAFLD patients, especially given the fact that for now, we do not have a good treatment option for NAFLD. Therefore, future investigations should combine studies on NAFLD and sarcopenia in terms of physical activity and nutritional interventions such as vitamin D supplementation. This review aims to report recent evidence concerning the links between sarcopenia and NAFLD and methods to assess sarcopenia.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaCanadian Journal of Gastroenterology and Hepatology
Brojčani podacivol. 2020, str. 1-12, 8859719
p-ISSN2291-2789
e-ISSN2291-2797
DOIhttps://doi.org/10.1155/2020/8859719
URN:NBNurn:nbn:hr:184:506848
Datum objave publikacije2020-10-31
URL dokumentahttps://www.hindawi.com/journals/cjgh/2020/8859719/
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2021-01-19 21:06:57